文献速递心外重症与机械循环支持

ProtekDuo套管无透视床旁植入的临床经验

Fluoroless bedside implantation of the ProtekDuo cannula: Clinical experience at a tertiary care center.
PubMed 文献 · J Heart Lung Transplant · 2025-09-23

单中心报告8例危重心肺衰竭患者在经食管超声(TEE)引导下于床旁完成无透视ProtekDuo双腔套管植入。全部操作成功,无操作相关并发症。提示床旁TEE引导无透视植入可行且安全,有望扩大晚期机械循环支持的可及性。

要点

  • TEE引导下床旁无透视ProtekDuo植入在8例危重患者中全部成功。
  • 无操作相关并发症,提示该路径安全可行。
  • 可减少对透视手术室的依赖,利于及时开展机械循环支持。

核心结论

  • 床旁、TEE引导、无透视的ProtekDuo套管植入可行且安全,可能扩大晚期机械循环支持的可及性。

研究设计与样本

  • 单中心回顾性病例系列,报告某国家级转诊中心8例危重患者的初始经验。
  • 患者因右心室功能障碍或急性呼吸窘迫综合征合并右心衰竭接受床旁ProtekDuo植入。

主要发现

  • 8例患者均完成床旁ProtekDuo植入。
  • 所有操作成功完成,无操作相关并发症。

临床怎么用

  • 对需右心室支持且不宜转运至透视手术室的患者,可考虑床旁TEE引导无透视ProtekDuo植入。
  • 操作中依据TEE引导完成套管定位,以避免透视依赖。

局限性

  • 为单中心初始经验,样本量为8例,未设对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The ProtekDuo dual-lumen cannula allows percutaneous support in right ventricular failure with or without gas exchange impairments. However, positioning of the device is resource demanding. The usual approach requires a fluoroscopy-equipped operating room, possibly limiting its wider and timely adoption. We report our initial experience with bedside, fluoroless ProtekDuo implantation under transesophageal echocardiography (TEE) guidance in a tertiary care national referral center. Eight critically ill patients underwent bedside ProtekDuo placement for right ventricular dysfunction or acute respiratory distress syndrome with right ventricular failure. All procedures were completed successfully without procedural complications. Our findings demonstrate that bedside, TEE-guided, fluoroless ProtekDuo cannulation is feasible and safe, potentially expanding access to advanced mechanical circulatory support.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Nardelli P, Altizio S, Fominskiy E, et al. Fluoroless bedside implantation of the ProtekDuo cannula: Clinical experience at a tertiary care center. J Heart Lung Transplant. 2025. PMID: 40998277. doi:10.1016/j.healun.2025.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。